{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:39:41Z","timestamp":1791639581788,"version":"4.3.4"},"reference-count":118,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T00:00:00Z","timestamp":1393286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T00:00:00Z","timestamp":1393286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Korean Health Technology R&D Project"},{"name":"Ministry of Health & Welfare"},{"name":"Republic of Korea","award":["HI07C0001"],"award-info":[{"award-number":["HI07C0001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1111\/jcpt.12136","type":"journal-article","created":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T05:18:37Z","timestamp":1393305517000},"page":"215-224","source":"Crossref","is-referenced-by-count":84,"title":["Current and potential therapeutic strategies for mucopolysaccharidoses"],"prefix":"10.1155","volume":"39","author":[{"given":"H.","family":"Noh","sequence":"first","affiliation":[{"name":"Department of Pharmacy; College of Pharmacy; Yonsei University; Incheon Korea"},{"name":"Yonsei Institute of Pharmaceutical Sciences; College of Pharmacy; Yonsei University; Incheon Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. I.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; College of Pharmacy; Yonsei University; Incheon Korea"},{"name":"Yonsei Institute of Pharmaceutical Sciences; College of Pharmacy; Yonsei University; Incheon Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2014,2,25]]},"reference":[{"key":"10.1111\/jcpt.12136-BIB0001|jcpt12136-cit-0001","first-page":"3421","volume-title":"The metabolic and molecular bases of inherited disease","author":"Neufeld","year":"2001","edition":"8"},{"key":"10.1111\/jcpt.12136-BIB0002|jcpt12136-cit-0002","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/adc.72.3.263","article-title":"The mucopolysaccharidoses: a clinical review and guide to management","volume":"72","author":"Wraith","year":"1995","journal-title":"Arch Dis Child"},{"issue":"Suppl 5","key":"10.1111\/jcpt.12136-BIB0003|jcpt12136-cit-0003","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/jcpt.12136-BIB0004|jcpt12136-cit-0004","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00431-011-1644-x","article-title":"Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry","volume":"171","author":"D'Aco","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1111\/jcpt.12136-BIB0005|jcpt12136-cit-0005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.a.34415","article-title":"Mucopolysaccharidosis type II in females and response to enzyme replacement therapy","volume":"158a","author":"Jurecka","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1111\/jcpt.12136-BIB0006|jcpt12136-cit-0006","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/GIM.0b013e31817701e6","article-title":"Initial report from the Hunter Outcome Survey","volume":"10","author":"Wraith","year":"2008","journal-title":"Genet Med"},{"key":"10.1111\/jcpt.12136-BIB0007|jcpt12136-cit-0007","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1111\/jcpt.12136-BIB0008|jcpt12136-cit-0008","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","article-title":"Sanfilippo syndrome: a mini-review","volume":"31","author":"Valstar","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1111\/jcpt.12136-BIB0009|jcpt12136-cit-0009","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2174\/138920111795542679","article-title":"Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses","volume":"12","author":"Pan","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1111\/jcpt.12136-BIB0010|jcpt12136-cit-0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1399-0004.1981.tb01821.x","article-title":"Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C)","volume":"20","author":"Kamp","year":"1981","journal-title":"Clin Genet"},{"key":"10.1111\/jcpt.12136-BIB0011|jcpt12136-cit-0011","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/mt.2010.265","article-title":"Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes","volume":"19","author":"Ellinwood","year":"2011","journal-title":"Mol Ther"},{"key":"10.1111\/jcpt.12136-BIB0012|jcpt12136-cit-0012","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2174\/138920111795542615","article-title":"Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment","volume":"12","author":"Tomatsu","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1111\/jcpt.12136-BIB0013|jcpt12136-cit-0013","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","article-title":"International Morquio A Registry: clinical manifestation and natural course of Morquio A disease","volume":"30","author":"Montano","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1111\/jcpt.12136-BIB0014|jcpt12136-cit-0014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.2006-2184","article-title":"Management guidelines for mucopolysaccharidosis VI","volume":"120","author":"Giugliani","year":"2007","journal-title":"Pediatrics"},{"key":"10.1111\/jcpt.12136-BIB0015|jcpt12136-cit-0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI","volume":"5","author":"Valayannopoulos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1111\/jcpt.12136-BIB0016|jcpt12136-cit-0016","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/humu.20828","article-title":"Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome)","volume":"30","author":"Tomatsu","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1111\/jcpt.12136-BIB0017|jcpt12136-cit-0017","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2012.07.002","article-title":"Long circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine model","volume":"107","author":"Rowan","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1111\/jcpt.12136-BIB0018|jcpt12136-cit-0018","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10545-011-9343-3","article-title":"A complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritis","volume":"34","author":"Imundo","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1111\/jcpt.12136-BIB0019|jcpt12136-cit-0019","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199610033351405","article-title":"Clinical and biochemical manifestations of hyaluronidase deficiency","volume":"335","author":"Natowicz","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12136-BIB0020|jcpt12136-cit-0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1747-0285.2008.00741.x","article-title":"The structure of glycosaminoglycans and their interactions with proteins","volume":"72","author":"Gandhi","year":"2008","journal-title":"Chem Biol Drug Des"},{"key":"10.1111\/jcpt.12136-BIB0021|jcpt12136-cit-0021","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1017\/S1462399408000550","article-title":"The mucopolysaccharidoses: a success of molecular medicine","volume":"10","author":"Clarke","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"10.1111\/jcpt.12136-BIB0022|jcpt12136-cit-0022","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10545-008-1040-5","article-title":"Pathogenic cascades in lysosomal disease-Why so complex?","volume":"32","author":"Walkley","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"10.1111\/jcpt.12136-BIB0023|jcpt12136-cit-0023","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1152\/physrev.2000.80.4.1267","article-title":"Proteoglycans in the developing brain: new conceptual insights for old proteins","volume":"80","author":"Bandtlow","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1111\/jcpt.12136-BIB0024|jcpt12136-cit-0024","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.expneurol.2004.04.017","article-title":"Perineuronal nets potentially protect against oxidative stress","volume":"188","author":"Morawski","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1111\/jcpt.12136-BIB0025|jcpt12136-cit-0025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.162.3853.570","article-title":"Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts","volume":"162","author":"Fratantoni","year":"1968","journal-title":"Science"},{"key":"10.1111\/jcpt.12136-BIB0026|jcpt12136-cit-0026","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1651-2227.2007.00202.x","article-title":"Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome","volume":"96","author":"Walkley","year":"2007","journal-title":"Acta Paediatr Suppl"},{"key":"10.1111\/jcpt.12136-BIB0027|jcpt12136-cit-0027","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/iub.284","article-title":"Therapy for lysosomal storage disorders","volume":"62","author":"Beck","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1111\/jcpt.12136-BIB0028|jcpt12136-cit-0028","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","article-title":"Common and uncommon pathogenic cascades in lysosomal storage diseases","volume":"285","author":"Vitner","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1111\/jcpt.12136-BIB0029|jcpt12136-cit-0029","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cne.20355","article-title":"Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders","volume":"480","author":"McGlynn","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1111\/jcpt.12136-BIB0030|jcpt12136-cit-0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semcdb.2004.03.002","article-title":"Secondary accumulation of gangliosides in lysosomal storage disorders","volume":"15","author":"Walkley","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"10.1111\/jcpt.12136-BIB0031|jcpt12136-cit-0031","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/cercor\/10.10.1028","article-title":"Gangliosides as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons","volume":"10","author":"Walkley","year":"2000","journal-title":"Cereb Cortex"},{"key":"10.1111\/jcpt.12136-BIB0032|jcpt12136-cit-0032","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jcpt.12136-BIB0033|jcpt12136-cit-0033","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.cdd.4401834","article-title":"Gangliosides as apoptotic signals in ER stress response","volume":"13","author":"d'Azzo","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1111\/jcpt.12136-BIB0034|jcpt12136-cit-0034","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/labinvest.3780345","article-title":"Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses","volume":"81","author":"Simonaro","year":"2001","journal-title":"Lab Invest"},{"key":"10.1111\/jcpt.12136-BIB0035|jcpt12136-cit-0035","unstructured":"Genzyme Corporation 2003 Aldurazyme \u00ae (laronidase)"},{"key":"10.1111\/jcpt.12136-BIB0036|jcpt12136-cit-0036","doi-asserted-by":"crossref","unstructured":"Shire Human Genetic Therapies Inc. 2006 Elaprase \u00ae (idursulfase)","DOI":"10.3833\/pdr.v2006i76.452"},{"key":"10.1111\/jcpt.12136-BIB0037|jcpt12136-cit-0037","unstructured":"BioMarin Pharmaceutical Inc. 2005 Naglazyme \u00ae (galsulfase)"},{"key":"10.1111\/jcpt.12136-BIB0038|jcpt12136-cit-0038","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/13543784.11.5.675","article-title":"Enzyme replacement therapy for the mucopolysaccharide storage disorders","volume":"11","author":"Kakkis","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"issue":"Suppl 1","key":"10.1111\/jcpt.12136-BIB0039|jcpt12136-cit-0039","first-page":"26","article-title":"Enzyme replacement therapy for lysosomal storage diseases","volume":"10","author":"Ohashi","year":"2012","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1111\/jcpt.12136-BIB0040|jcpt12136-cit-0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","article-title":"A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6\u00a0years","volume":"90","author":"Sifuentes","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1111\/jcpt.12136-BIB0041|jcpt12136-cit-0041","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet Med"},{"key":"10.1111\/jcpt.12136-BIB0042|jcpt12136-cit-0042","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2165\/00003495-200767180-00005","article-title":"Treatment of lysosomal storage disorders: progress with enzyme replacement therapy","volume":"67","author":"Rohrbach","year":"2007","journal-title":"Drugs"},{"key":"10.1111\/jcpt.12136-BIB0043|jcpt12136-cit-0043","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J Pediatr"},{"key":"10.1111\/jcpt.12136-BIB0044|jcpt12136-cit-0044","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"key":"10.1111\/jcpt.12136-BIB0045|jcpt12136-cit-0045","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5\u00a0years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"120","author":"Wraith","year":"2007","journal-title":"Pediatrics"},{"key":"10.1111\/jcpt.12136-BIB0046|jcpt12136-cit-0046","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s10545-006-0457-y","article-title":"Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome","volume":"29","author":"Thomas","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1111\/jcpt.12136-BIB0047|jcpt12136-cit-0047","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pediatrneurol.2012.08.010","article-title":"Enzyme replacement therapy in an attenuated case of mucopolysaccharidosis type I (Scheie syndrome): a 6.5-year detailed follow-up","volume":"47","author":"Jurecka","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1111\/jcpt.12136-BIB0048|jcpt12136-cit-0048","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.amjcard.2006.02.047","article-title":"Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I","volume":"98","author":"Braunlin","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1111\/jcpt.12136-BIB0049|jcpt12136-cit-0049","unstructured":"Australian Government Department of Health and Ageing Guidelines for the treatment of Mucopolysaccharidosis Type I (MPS I) disease through the Life Saving Drugs Program 2013 http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/lsdp-info\/#Laronidase"},{"key":"10.1111\/jcpt.12136-BIB0050|jcpt12136-cit-0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1172-6-55","article-title":"Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure","volume":"6","author":"Ru","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1111\/jcpt.12136-BIB0051|jcpt12136-cit-0051","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"key":"10.1111\/jcpt.12136-BIB0052|jcpt12136-cit-0052","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet Med"},{"key":"10.1111\/jcpt.12136-BIB0053|jcpt12136-cit-0053","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/GIM.0b013e318206786f","article-title":"Idursulfase treatment of Hunter syndrome in children younger than 6\u00a0years: results from the Hunter Outcome Survey","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet Med"},{"key":"10.1111\/jcpt.12136-BIB0054|jcpt12136-cit-0054","first-page":"253","article-title":"Long-term enzyme replacement therapy in a severe case of mucopolysaccharidosis type II (Hunter syndrome)","volume":"15","author":"Papadia","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1111\/jcpt.12136-BIB0055|jcpt12136-cit-0055","unstructured":"Australian Government Department of Health and Ageing Guidelines for the treatment of Mucopolysaccharidosis Type II (MPS II) disease through the Life Saving Drugs Program 2012 http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/lsdp-info\/#Idursulfase"},{"key":"10.1111\/jcpt.12136-BIB0056|jcpt12136-cit-0056","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-6-72","article-title":"Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease","volume":"6","author":"Scarpa","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1111\/jcpt.12136-BIB0057|jcpt12136-cit-0057","unstructured":"Australian Government Department of Health and Ageing Guidelines for the treatment of Mucopolysaccharidosis Type VI (MPS VI) disease through the Life Saving Drugs Program 2013 http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/lsdp-info\/#Galsulfase"},{"key":"10.1111\/jcpt.12136-BIB0058|jcpt12136-cit-0058","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)","volume":"144","author":"Harmatz","year":"2004","journal-title":"J Pediatr"},{"key":"10.1111\/jcpt.12136-BIB0059|jcpt12136-cit-0059","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1542\/peds.2004-1023","article-title":"Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48\u00a0weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"115","author":"Harmatz","year":"2005","journal-title":"Pediatrics"},{"key":"10.1111\/jcpt.12136-BIB0060|jcpt12136-cit-0060","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study","volume":"148","author":"Harmatz","year":"2006","journal-title":"J Pediatr"},{"key":"10.1111\/jcpt.12136-BIB0061|jcpt12136-cit-0061","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ymgme.2008.04.001","article-title":"Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"94","author":"Harmatz","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1111\/jcpt.12136-BIB0062|jcpt12136-cit-0062","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10545-009-9007-8","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase","volume":"33","author":"Harmatz","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1111\/jcpt.12136-BIB0063|jcpt12136-cit-0063","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bmt.1704105","article-title":"Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources","volume":"31","author":"Souillet","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/jcpt.12136-BIB0064|jcpt12136-cit-0064","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(98)70201-X","article-title":"Follow-up of nine patients with Hurler syndrome after bone marrow transplantation","volume":"133","author":"Guffon","year":"1998","journal-title":"J Pediatr"},{"key":"10.1111\/jcpt.12136-BIB0065|jcpt12136-cit-0065","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJM198412203112504","article-title":"Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24\u00a0months after transplantation","volume":"311","author":"Krivit","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12136-BIB0066|jcpt12136-cit-0066","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","article-title":"Transplant outcomes in mucopolysaccharidoses","volume":"47","author":"Prasad","year":"2010","journal-title":"Semin Hematol"},{"key":"10.1111\/jcpt.12136-BIB0067|jcpt12136-cit-0067","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","article-title":"Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group","volume":"91","author":"Peters","year":"1998","journal-title":"Blood"},{"key":"10.1111\/jcpt.12136-BIB0068|jcpt12136-cit-0068","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","article-title":"Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome","volume":"87","author":"Peters","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jcpt.12136-BIB0069|jcpt12136-cit-0069","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajmg.1320460222","article-title":"Long-term outcome of Hurler syndrome following bone marrow transplantation","volume":"46","author":"Whitley","year":"1993","journal-title":"Am J Med Genet"},{"key":"10.1111\/jcpt.12136-BIB0070|jcpt12136-cit-0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00711387","article-title":"Bone marrow transplantation in Hunter syndrome","volume":"18","author":"Coppa","year":"1995","journal-title":"J Inherit Metab Dis"},{"key":"10.1111\/jcpt.12136-BIB0071|jcpt12136-cit-0071","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","article-title":"Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17\u00a0years","volume":"154","author":"Guffon","year":"2009","journal-title":"J Pediatr"},{"key":"10.1111\/jcpt.12136-BIB0072|jcpt12136-cit-0072","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-3476(96)70202-0","article-title":"Bone marrow transplantation in Hunter syndrome","volume":"129","author":"McKinnis","year":"1996","journal-title":"J Pediatr"},{"key":"10.1111\/jcpt.12136-BIB0073|jcpt12136-cit-0073","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2008-03-140830","article-title":"Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes","volume":"112","author":"Prasad","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jcpt.12136-BIB0074|jcpt12136-cit-0074","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.GIM.0000154299.22120.6A","article-title":"Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome","volume":"7","author":"Grewal","year":"2005","journal-title":"Genet Med"},{"key":"10.1111\/jcpt.12136-BIB0075|jcpt12136-cit-0075","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.bmt.1705934","article-title":"Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome","volume":"41","author":"Tolar","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/jcpt.12136-BIB0076|jcpt12136-cit-0076","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpeds.2008.07.004","article-title":"Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients","volume":"154","author":"Wynn","year":"2009","journal-title":"J Pediatr"},{"issue":"Suppl 5","key":"10.1111\/jcpt.12136-BIB0077|jcpt12136-cit-0077","doi-asserted-by":"crossref","first-page":"v49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","volume":"50","author":"Valayannopoulos","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 5","key":"10.1111\/jcpt.12136-BIB0078|jcpt12136-cit-0078","doi-asserted-by":"crossref","first-page":"v26","DOI":"10.1093\/rheumatology\/ker393","article-title":"Orthopaedic aspects of mucopolysaccharidoses","volume":"50","author":"White","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/jcpt.12136-BIB0079|jcpt12136-cit-0079","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1093\/hmg\/ddq420","article-title":"Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy","volume":"19","author":"Polito","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1111\/jcpt.12136-BIB0080|jcpt12136-cit-0080","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jcpt.12136-BIB0081|jcpt12136-cit-0081","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.expneurol.2011.04.004","article-title":"Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA","volume":"230","author":"Rozaklis","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1111\/jcpt.12136-BIB0082|jcpt12136-cit-0082","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I","volume":"83","author":"Kakkis","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1111\/jcpt.12136-BIB0083|jcpt12136-cit-0083","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ymgme.2004.05.005","article-title":"Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA","volume":"82","author":"Savas","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1111\/jcpt.12136-BIB0084|jcpt12136-cit-0084","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/pr.2011.13","article-title":"Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats","volume":"71","author":"Auclair","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1111\/jcpt.12136-BIB0085|jcpt12136-cit-0085","doi-asserted-by":"crossref","first-page":"e30341","DOI":"10.1371\/journal.pone.0030341","article-title":"CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder","volume":"7","author":"Calias","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/jcpt.12136-BIB0086|jcpt12136-cit-0086","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/mp200136x","article-title":"Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein","volume":"8","author":"Boado","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1111\/jcpt.12136-BIB0087|jcpt12136-cit-0087","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/mt.2010.32","article-title":"Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome","volume":"18","author":"Tomatsu","year":"2010","journal-title":"Mol Ther"},{"key":"10.1111\/jcpt.12136-BIB0088|jcpt12136-cit-0088","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1073\/pnas.0308728100","article-title":"Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice","volume":"101","author":"LeBowitz","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jcpt.12136-BIB0089|jcpt12136-cit-0089","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1203\/01.pdr.0000233037.00707.da","article-title":"Inhibition of glycosaminoglycan synthesis using rhodamine B in a mouse model of mucopolysaccharidosis type IIIA","volume":"60","author":"Roberts","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1111\/jcpt.12136-BIB0090|jcpt12136-cit-0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymgme.2007.06.016","article-title":"Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA","volume":"92","author":"Roberts","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1111\/jcpt.12136-BIB0091|jcpt12136-cit-0091","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2174\/138920111798376932","article-title":"Substrate reduction therapies for mucopolysaccharidoses","volume":"12","author":"Jakobkiewicz-Banecka","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1111\/jcpt.12136-BIB0092|jcpt12136-cit-0092","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1423-0127-16-26","article-title":"Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway","volume":"16","author":"Jakobkiewicz-Banecka","year":"2009","journal-title":"J Biomed Sci"},{"key":"10.1111\/jcpt.12136-BIB0093|jcpt12136-cit-0093","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1476-5381.2009.00565.x","article-title":"Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II","volume":"159","author":"Friso","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jcpt.12136-BIB0094|jcpt12136-cit-0094","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2009.06.013","article-title":"Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice","volume":"98","author":"Malinowska","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1111\/jcpt.12136-BIB0095|jcpt12136-cit-0095","doi-asserted-by":"crossref","first-page":"e14192","DOI":"10.1371\/journal.pone.0014192","article-title":"Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease","volume":"5","author":"Malinowska","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1111\/jcpt.12136-BIB0096|jcpt12136-cit-0096","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/ajmg.a.34146","article-title":"Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT)","volume":"155a","author":"Marucha","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1111\/jcpt.12136-BIB0097|jcpt12136-cit-0097","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.curtheres.2008.04.002","article-title":"Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: an open-label, pilot study in 10 pediatric patients","volume":"69","author":"Piotrowska","year":"2008","journal-title":"Current therapeutic research, clinical and experimental"},{"key":"10.1111\/jcpt.12136-BIB0098|jcpt12136-cit-0098","doi-asserted-by":"crossref","first-page":"Cr196","DOI":"10.12659\/MSM.881715","article-title":"Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients","volume":"17","author":"Piotrowska","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.1111\/jcpt.12136-BIB0099|jcpt12136-cit-0099","unstructured":"Actelion Pharmaceuticals US Inc. 2003 Zavesca \u00ae (miglustat)"},{"key":"10.1111\/jcpt.12136-BIB0100|jcpt12136-cit-0100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1111\/jcpt.12136-BIB0101|jcpt12136-cit-0101","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","article-title":"The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement","volume":"26","author":"Cox","year":"2003","journal-title":"J Inherit Metab Dis"},{"issue":"838-844","key":"10.1111\/jcpt.12136-BIB0102|jcpt12136-cit-0102","first-page":"e831","article-title":"Evaluation of miglustat treatment in patients with type III mucopolysaccharidosis: a randomized, double-blind, placebo-controlled study","volume":"159","author":"Guffon","year":"2011","journal-title":"J Pediatr"},{"key":"10.1111\/jcpt.12136-BIB0103|jcpt12136-cit-0103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/exnr.1999.7176","article-title":"Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice","volume":"160","author":"Skorupa","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1111\/jcpt.12136-BIB0104|jcpt12136-cit-0104","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/gt.2009.36","article-title":"Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery","volume":"16","author":"Richard","year":"2009","journal-title":"Gene Ther"},{"key":"10.1111\/jcpt.12136-BIB0105|jcpt12136-cit-0105","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1523\/JNEUROSCI.3558-04.2004","article-title":"Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum","volume":"24","author":"Cressant","year":"2004","journal-title":"J Neurosci"},{"key":"10.1111\/jcpt.12136-BIB0106|jcpt12136-cit-0106","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1523\/JNEUROSCI.2936-05.2005","article-title":"Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors","volume":"25","author":"Liu","year":"2005","journal-title":"J Neurosci"},{"key":"10.1111\/jcpt.12136-BIB0107|jcpt12136-cit-0107","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/mthe.2001.0274","article-title":"Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII","volume":"3","author":"Frisella","year":"2001","journal-title":"Mol Ther"},{"key":"10.1111\/jcpt.12136-BIB0108|jcpt12136-cit-0108","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1089\/hum.2012.029","article-title":"Correction of pathological accumulation of glycosaminoglycans in central nervous system and peripheral tissues of MPSIIIA mice through systemic AAV9 gene transfer","volume":"23","author":"Ruzo","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1111\/jcpt.12136-BIB0109|jcpt12136-cit-0109","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/mt.2011.34","article-title":"Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood-brain barrier gene delivery","volume":"19","author":"Fu","year":"2011","journal-title":"Mol Ther"},{"key":"10.1111\/jcpt.12136-BIB0110|jcpt12136-cit-0110","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/gt.2009.85","article-title":"Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice","volume":"16","author":"McCarty","year":"2009","journal-title":"Gene Ther"},{"key":"10.1111\/jcpt.12136-BIB0111|jcpt12136-cit-0111","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1517\/14712598.7.9.1333","article-title":"Gene therapy for mucopolysaccharidosis","volume":"7","author":"Ponder","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"10.1111\/jcpt.12136-BIB0112|jcpt12136-cit-0112","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.ymgme.2012.11.110","article-title":"A multi-national, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of BMN 110 treatment for mucopolysaccharidosis IVA (Morquio syndrome type A)","volume":"108","author":"Hendriksz","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1111\/jcpt.12136-BIB0113|jcpt12136-cit-0113","unstructured":"GenomeNet Kyoto University Bioinformatics Center Kyoto, Japan http:\/\/www.genome.jp\/kegg\/"},{"key":"10.1111\/jcpt.12136-BIB0114|jcpt12136-cit-0114","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004390050641","article-title":"Incidence of the mucopolysaccharidoses in Northern Ireland","volume":"101","author":"Nelson","year":"1997","journal-title":"Hum Genet"},{"key":"10.1111\/jcpt.12136-BIB0115|jcpt12136-cit-0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-3-24","article-title":"The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1111\/jcpt.12136-BIB0116|jcpt12136-cit-0116","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1542\/peds.105.1.e10","article-title":"Incidence of inborn errors of metabolism in British Columbia, 1969-1996","volume":"105","author":"Applegarth","year":"2000","journal-title":"Pediatrics"},{"key":"10.1111\/jcpt.12136-BIB0117|jcpt12136-cit-0117","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"Baehner","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1111\/jcpt.12136-BIB0118|jcpt12136-cit-0118","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00206770","article-title":"An update on the frequency of mucopolysaccharide syndromes in British Columbia","volume":"85","author":"Lowry","year":"1990","journal-title":"Hum Genet"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12136","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12136","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12136\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T15:06:23Z","timestamp":1716563183000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,25]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12136","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,25]]}}}